12/9/2023 0 Comments Otcmkts semhfChamp Bailey will moderate the eventĬhamp Bailey, a football Hall of Famer and the chief diversity officer at Trulieve Georgia, will moderate the event. It will cover topics like expungement, agricultural, economic, and medical opportunities in the cannabis industry. The tour aims to meet with local leaders and exchange ideas. Trulieve Cannabis Corp (OTCMKTS: TCNNF) will host a Listening and Education Tour. It has its headquarters in Vancouver, Canada. Moreover, it shipped cannabis products to wholesalers in Europe.Įmerald Health’s name was T-Bird Pharma Inc until it changed its name in 2015. The company sold its products through wholesale clients and pharmacies with licenses. The company sold oils, ingestible extracts, pre-rolls, and dried strains. The company will announce its successor before the year ends.įor the last few years, Emerald Health Therapeutics has focused on producing and selling medical-use cannabis. With the change in the company’s direction, Bandali is now ready to seek new opportunities. The CEO had increased Emerald’s cash positions and restructured the balance sheet. Bandali has worked for two years for the company to bring financial stability. Riaz Bandali, the CEO and President of Emerald Health, will resign by December 31. The company is excited to move in a path that would increase value for shareholders and ensure profitability. Instead, it has chosen to move into the pharmaceutical development industry, where it will better serve its shareholders. Heppell adds that Emerald had decided against investing in the cannabis market. Regulators are issuing more licenses to cannabis operators, thus increasing competition, reducing prices and profitability. Changes in the cannabis market make it harder to reach profitabilityĪccording to the Board of Directors chairman, Jim Heppell, while the Emerald team has shown great expertise and detection to its cannabis customers, the cannabis industry is experiencing many changes. Vantage Point is a valuation firm with operations in Dallas-Fort Worth, Seattle, Portland, San Diego, Los Angeles, and New York. The company will have to wait for shareholder approval to continue its plans.Įmerald will keep its Vantage Point Advisors for help in identifying pharmaceutical operations that they could acquire and consisting due diligence on these companies. It will also help cut back on its spending to lower net burn per month.Įmerald Health will strengthen its position in market areas where its board already has the expertise. The company plans to sell its cannabis assets to increase its working capital. Emerald Health Therapeutics Inc (OTCMKTS: EMHTF) has announced that it will transition from the adult and medical-use cannabis markets to a pharmaceutical business.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |